168 related articles for article (PubMed ID: 32628088)
21. Functional polymorphisms in FAS/FASL system increase the risk of neuroblastoma in Chinese population.
Han W; Zhou Y; Zhong R; Wu C; Song R; Liu L; Zou L; Qiao Y; Zhai K; Chang J; Huang L; Liu L; Lu X; Lou J; Yu D; Tan W; Zhang J; Wang H; Miao X
PLoS One; 2013; 8(8):e71656. PubMed ID: 23951214
[TBL] [Abstract][Full Text] [Related]
22. Association of Clinical Aspects and Genetic Variants with the Severity of Cisplatin-Induced Ototoxicity in Head and Neck Squamous Cell Carcinoma: A Prospective Cohort Study.
Macedo LT; Costa EFD; Carvalho BF; Lourenço GJ; Calonga L; Castilho AM; Chone CT; Lima CSP
Cancers (Basel); 2023 Mar; 15(6):. PubMed ID: 36980643
[TBL] [Abstract][Full Text] [Related]
23. A polymorphic -844T/C in FasL promoter predicts survival and relapse in non-small cell lung cancer.
Sung WW; Wang YC; Cheng YW; Lee MC; Yeh KT; Wang L; Wang J; Chen CY; Lee H
Clin Cancer Res; 2011 Sep; 17(18):5991-9. PubMed ID: 21807637
[TBL] [Abstract][Full Text] [Related]
24. Single-Nucleotide Polymorphisms of FAS and FASL Genes and Risk of Idiopathic Aplastic Anemia.
Rehman S; Saba N; Naz M; Ahmed P; Munir S; Sajjad S; Tabassum S; Naseem L
Immunol Invest; 2018 Jul; 47(5):484-491. PubMed ID: 29611722
[TBL] [Abstract][Full Text] [Related]
25. Single-nucleotide gene polymorphisms involving cell death pathways: a study of Chinese patients with lumbar disc herniation.
Sun Z; Ling M; Chang Y; Huo Y; Yang G; Ji Y; Li Y
Connect Tissue Res; 2013; 54(1):55-61. PubMed ID: 23205884
[TBL] [Abstract][Full Text] [Related]
26. Fas -670 A/G polymorphism predicts prognosis of hepatocellular carcinoma after curative resection in Chinese Han population.
Guo XY; Xia YL; Li ZY; Li R; Fan Y; Yao WM; Liu F
Hepatobiliary Pancreat Dis Int; 2022 Feb; 21(1):33-40. PubMed ID: 34366198
[TBL] [Abstract][Full Text] [Related]
27. Targeted next-generation sequencing of locally advanced squamous cell carcinomas of the head and neck reveals druggable targets for improving adjuvant chemoradiation.
Tinhofer I; Budach V; Saki M; Konschak R; Niehr F; Jöhrens K; Weichert W; Linge A; Lohaus F; Krause M; Neumann K; Endris V; Sak A; Stuschke M; Balermpas P; Rödel C; Avlar M; Grosu AL; Abdollahi A; Debus J; Belka C; Pigorsch S; Combs SE; Mönnich D; Zips D; Baumann M;
Eur J Cancer; 2016 Apr; 57():78-86. PubMed ID: 26896955
[TBL] [Abstract][Full Text] [Related]
28. IL6 and FAS/FASL gene polymorphisms may be associated with disease progression in HIV-1-positive ethnically mixed patients.
Loureiro Dos Reis MM; Queiroz MAF; da Silva BCM; da Silva Duarte AJ; Casseb J; Arganaraz GA; Vallinoto ACR; Argañaraz ER
J Med Virol; 2020 Aug; 92(8):1148-1157. PubMed ID: 31825106
[TBL] [Abstract][Full Text] [Related]
29. Is there a role for the Fas-/Fas-Ligand pathway in chemoresistance of human squamous cell carcinomas of the head and neck (SCCHN)?
Sproll KC; Balló H; Hoffmann TK; Scheckenbach K; Koldovsky U; Balz V; Hafner D; Ramp U; Bier H
Oral Oncol; 2009 Jan; 45(1):69-84. PubMed ID: 18620901
[TBL] [Abstract][Full Text] [Related]
30. Radiotherapy potentiation with weekly cisplatin compared to standard every 3 weeks cisplatin chemotherapy for locoregionally advanced head and neck squamous cell carcinoma.
Fayette J; Molin Y; Lavergne E; Montbarbon X; Racadot S; Poupart M; Ramade A; Zrounba P; Ceruse P; Pommier P
Drug Des Devel Ther; 2015; 9():6203-10. PubMed ID: 26648696
[TBL] [Abstract][Full Text] [Related]
31. FASL polymorphism is associated with response to bacillus Calmette-Guérin immunotherapy in bladder cancer.
Lima L; Ferreira JA; Tavares A; Oliveira D; Morais A; Videira PA; Medeiros R; Santos L
Urol Oncol; 2014 Jan; 32(1):44.e1-7. PubMed ID: 23948181
[TBL] [Abstract][Full Text] [Related]
32. Matrix metalloproteinase 3 polymorphism: a predictive factor of response to neoadjuvant chemotherapy in head and neck squamous cell carcinoma.
Blons H; Gad S; Zinzindohoué F; Manière I; Beauregard J; Tregouet D; Brasnu D; Beaune P; Laccourreye O; Laurent-Puig P
Clin Cancer Res; 2004 Apr; 10(8):2594-9. PubMed ID: 15102660
[TBL] [Abstract][Full Text] [Related]
33. ATM, BCL2, and TGFβ Gene Polymorphisms as Radiotherapy Outcome Biomarkers in Head and Neck Squamous Cell Carcinoma Patients.
Agostini LP; Stur E; Garcia FM; Ventorim DP; Dos Reis RS; Dettogni RS; Dos Santos EVW; Peterle GT; Maia LL; Mendes SO; de Carvalho MB; Tajara EH; de Paula F; Dos Santos M; da Silva AMA; Louro ID
Genet Test Mol Biomarkers; 2017 Dec; 21(12):727-735. PubMed ID: 29135311
[TBL] [Abstract][Full Text] [Related]
34. Association of FAS-670A/G and FASL-844C/T polymorphisms with idiopathic azoospermia in Western Iran.
Asgari R; Mansouri K; Bakhtiari M; Bidmeshkipour A; Yari K; Shaveisi-Zadeh F; Vaisi-Raygani A
Eur J Obstet Gynecol Reprod Biol; 2017 Nov; 218():55-59. PubMed ID: 28942044
[TBL] [Abstract][Full Text] [Related]
35. The relationship between Fas and Fas ligand gene polymorphism and preeclampsia risk.
Wang T; Lian Y
Biosci Rep; 2019 Feb; 39(2):. PubMed ID: 30718366
[TBL] [Abstract][Full Text] [Related]
36. Apoptosis-related Fas and FasL gene polymorphisms' associations with knee osteoarthritis.
Sezgin M; Barlas İÖ; Yıldır S; Türköz G; Ankaralı HÇ; Şahin G; Erdal ME
Rheumatol Int; 2013 Aug; 33(8):2039-43. PubMed ID: 23392773
[TBL] [Abstract][Full Text] [Related]
37. Functional polymorphisms of FAS and FASL gene and risk of breast cancer - pilot study of 134 cases.
Hashemi M; Fazaeli A; Ghavami S; Eskandari-Nasab E; Arbabi F; Mashhadi MA; Taheri M; Chaabane W; Jain MV; Łos MJ
PLoS One; 2013; 8(1):e53075. PubMed ID: 23326385
[TBL] [Abstract][Full Text] [Related]
38. Concurrent Chemoradiation with Weekly Cisplatin for the Treatment of Head and Neck Cancers: an Institutional Study on Acute Toxicity and Response to Treatment.
Ghosh S; Rao PB; Kumar PR; Manam S
Asian Pac J Cancer Prev; 2015; 16(16):7331-5. PubMed ID: 26514533
[TBL] [Abstract][Full Text] [Related]
39. Functional polymorphisms in FAS and FASL contribute to increased apoptosis of tumor infiltration lymphocytes and risk of breast cancer.
Zhang B; Sun T; Xue L; Han X; Zhang B; Lu N; Shi Y; Tan W; Zhou Y; Zhao D; Zhang X; Guo Y; Lin D
Carcinogenesis; 2007 May; 28(5):1067-73. PubMed ID: 17183065
[TBL] [Abstract][Full Text] [Related]
40. Genetic polymorphisms in FAS (CD95) and FAS ligand (CD178) promoters and risk of tobacco-related oral carcinoma: gene-gene interactions in high-risk Indians.
Karimi MY; Kapoor V; Sharma SC; Das SN
Cancer Invest; 2013 Jan; 31(1):1-6. PubMed ID: 23153021
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
